Monica Carpenedo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study.
Journal: Thyroid : official journal of the American Thyroid Association
Published: June 24, 2026
Real-world experiences with subcutaneous therapy in adults with primary immune thrombocytopenia: A dual cross-sectional survey study of patients and clinicians in Italy.
Journal: Therapeutic advances in hematology
Published: December 24, 2025
Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study.
Journal: British journal of haematology
Published: March 31, 2025
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience.
Journal: Platelets
Published: December 06, 2024
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 10, 2024
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey.
Journal: European journal of haematology
Published: April 10, 2024
Perioperative ROTEM® evaluation in a patient affected by severe VII factor deficiency undergoing microvascular decompression craniotomy for hemifacial spasm.
Journal: Journal of clinical monitoring and computing
Published: April 05, 2024
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: May 05, 2023
Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.
Journal: Mediterranean journal of hematology and infectious diseases
Published: December 27, 2022
Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.
Journal: Mediterranean journal of hematology and infectious diseases
Published: December 22, 2022
Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel.
Journal: Haematologica
Published: February 19, 2022
Last Updated: 09/26/2026